Skip to content Skip to contact
Global Vox Populi

Patient market research in Nigeria

Understanding Patient Experiences in Nigeria

Nigeria’s healthcare sector is undergoing significant transformation, with increasing demand for patient-centric approaches and outcomes data.

Understanding the nuanced experiences of patients across its diverse regions is critical for pharmaceutical companies, medical device manufacturers, and healthcare providers.

The Nigeria Data Protection Act (NDPA) 2023 sets the framework for handling personal health information, requiring careful consideration in all research activities. Global Vox Populi manages these requirements, delivering reliable patient market research in Nigeria.

What we research in Nigeria

In Nigeria, patient market research addresses core strategic questions for healthcare stakeholders.

We explore patient journeys from symptom recognition through diagnosis, treatment, and recovery, identifying key touchpoints and pain points. Our studies assess patient needs, unmet medical needs, and perceptions of disease burden, informing product development and communication strategies.

We also conduct research on medication adherence, patient satisfaction with care pathways, and the adoption of digital health solutions. Each project scope is carefully customized to align with specific client objectives and the local healthcare context.

Why Patient market research fits (or struggles) in Nigeria

Patient market research in Nigeria can yield rich insights, particularly when engaging with patients in urban centers like Lagos, Abuja, and Port Harcourt, where healthcare infrastructure is more developed.

Recruitment through hospitals, clinics, and established patient advocacy groups can be effective for specific conditions. However, challenges exist in reaching patients in rural areas due to limited healthcare access and lower health literacy.

Stigma associated with certain diseases also impacts willingness to participate. Language diversity across Nigeria requires multi-lingual moderation, and digital connectivity gaps can limit online recruitment.

For these reasons, we often recommend in-person qualitative approaches or CAPI (Computer Assisted Personal Interviewing) for broader geographic reach, adapting to local realities.

How we run Patient market research in Nigeria

Our patient market research in Nigeria begins with ethical recruitment.

We source participants through partnerships with healthcare facilities, patient support organizations, and sometimes through physician referrals, always delivering explicit patient consent and adherence to ethical guidelines.

Screening involves detailed medical history verification, often requiring confirmation of diagnosis from medical records (with patient authorization) and strict recent-participation checks.

Fieldwork typically involves in-depth interviews (IDIs), conducted either in-person at secure, private locations or remotely via secure video platforms. We also implement patient diaries or ethnographic observations for a deeper understanding of daily experiences.

Interviews are conducted in English, Yoruba, Hausa, Igbo, and Nigerian Pidgin. Our moderators are local, fluent in relevant languages, often with a healthcare or psychology background, and trained in sensitive interviewing techniques.

Quality assurance includes double-listening to audio, back-translating key quotes, and regular debriefs with moderators. Deliverables range from verbatim transcripts and thematic summaries to patient journey maps, detailed reports, and debrief decks.

Project management follows a structured cadence, with transparent communication throughout.

Where we field in Nigeria

Global Vox Populi conducts patient market research across Nigeria, with strong capabilities in major urban centers.

We frequently field projects in Lagos, Abuja, Port Harcourt, Kano, and Ibadan, covering a significant portion of the country’s patient population. Beyond these metros, our network extends to state capitals and larger towns, using local field teams for broader reach.

For rural patient populations, we implement strategies involving community health centers and mobile fieldwork teams, delivering access to diverse patient segments.

Our language capabilities cover the predominant languages of Nigeria, including English, Yoruba, Hausa, and Igbo, allowing for culturally appropriate engagement across various regions.

Methodology, standards, and ethics

We adhere to stringent ethical and methodological standards for patient market research.

Our work aligns with ESOMAR and the ICC/ESOMAR International Code on Market, Opinion and Social Research and Data Analytics (2016 revision), alongside ISO 20252:2019 where applicable.

We also operate in accordance with the principles set forth by the Nigerian Institute of Market Research (NIMR), delivering local relevance.

Our methodology framework for patient research draws from best practices in qualitative inquiry, including semi-structured guides for IDIs, laddering techniques to explore underlying motivations, and established frameworks for patient journey mapping.

Applying these standards means every patient participant provides explicit, informed consent, understanding the research purpose, data handling, and their right to withdraw. We make clear disclosures about anonymization and confidentiality protocols.

For sensitive health topics, we seek ethical review board (IRB/IEC) approval as required by local regulations or client mandates, safeguarding patient welfare.

Quality assurance is integral to our process. This includes peer review of discussion guides and screening questionnaires, daily debriefs with moderators to capture emerging themes, and thorough verification of transcripts.

For qualitative outputs, our analysts perform rigorous thematic coding and cross-validation, delivering the integrity and accuracy of the patient insights delivered.

Drivers and barriers for Patient market research in Nigeria

DRIVERS:

  • Nigeria’s growing healthcare sector and increasing health awareness among its population drive demand for patient insights.
  • Urban areas show rising digital health adoption, supporting online recruitment for some segments.
  • Patients are often willing to share their experiences to improve healthcare outcomes, especially for chronic conditions.
  • The focus on patient-centric care by global pharmaceutical companies operating in Nigeria also fuels this research investment.
  • Nigeria’s healthcare spending is projected to grow significantly annually through 2028.

BARRIERS:

  • Data privacy concerns, particularly around sensitive health information, necessitate reliable consent protocols.
  • Low health literacy in certain rural segments can complicate recruitment and data collection.
  • Stigma associated with specific diseases can make patient recruitment challenging.
  • Limited access to specialized healthcare facilities in remote areas restricts the reach of in-person studies.
  • Overcoming language barriers and delivering cultural sensitivity across Nigeria’s diverse ethnic groups requires careful planning and skilled local teams.

Compliance and data handling under Nigeria’s framework

All patient market research conducted in Nigeria adheres strictly to the Nigeria Data Protection Act (NDPA) 2023.

This framework mandates explicit, informed consent for the collection and processing of personal data, especially sensitive health information. We deliver purpose limitation, meaning data is only used for the stated research objectives. Data minimization principles guide us to collect only necessary information.

Anonymization and pseudonymization techniques are applied to patient data wherever possible to protect identities. Patients are fully informed of their rights, including the right to access their data, rectify inaccuracies, and withdraw consent at any time.

We implement reliable security measures to protect data during collection, storage, and transfer, in line with NDPA requirements.

Top 20 industries we serve in Nigeria

  • Pharmaceuticals & Biotech: Patient journey mapping, unmet needs assessment, medication adherence studies.
  • Healthcare Providers: Patient experience research, hospital choice drivers, satisfaction with clinical services.
  • Medical Devices & Diagnostics: Patient acceptance of new devices, usability studies, post-market surveillance.
  • Health Technology (HealthTech): Digital health app usability, telemedicine adoption, patient portal feedback.
  • FMCG & CPG (Health & Wellness): Consumer health product usage, self-care practices, perception of health claims.
  • Insurance (Health): Policyholder experience, claims process satisfaction, health plan preference.
  • Government & Public Health: Disease burden perception, health campaign effectiveness, public health policy impact.
  • NGO & Development (Health Focus): Program evaluation for health initiatives, beneficiary needs assessment.
  • Food & Nutrition: Dietary habits of patient groups, nutritional supplement perceptions, health-related food choices.
  • Personal Care & Hygiene: Product usage for specific health conditions, impact on quality of life.
  • Banking & Financial Services: Financial literacy for healthcare costs, payment solutions for medical services.
  • Telecommunications: Role of mobile in health information access, digital health service delivery.
  • Education: Health education needs, patient literacy programs, medical training feedback.
  • Retail Pharmacy: Patient experience at pharmacies, medication counseling effectiveness, OTC product choice.
  • Logistics & Supply Chain (Pharma): Patient access to medicines, supply chain reliability perception.
  • Chemicals (Healthcare): Raw material sourcing impact on medical product perception.
  • Automotive (Ambulance/Medical Transport): Patient transport experience, emergency service satisfaction.
  • Real Estate (Healthcare Facilities): Location preference for clinics, design impact on patient comfort.
  • Media & Entertainment (Health Content): Patient engagement with health-related media, information seeking behavior.
  • Agriculture (Nutritional Security): Impact of food production on patient health outcomes in rural areas.

Companies and brands in our research universe in Nigeria

Research projects we field in Nigeria regularly cover the competitive sets of category leaders such as GSK, Pfizer, Novartis, Sanofi, Emzor Pharmaceutical Industries, Fidson Healthcare Plc, Dangote Cement, MTN Nigeria, Globacom, Airtel Nigeria, Guaranty Trust Bank, Zenith Bank, Access Bank, First Bank of Nigeria, Unilever Nigeria, Procter & Gamble Nigeria, Nestle Nigeria, TotalEnergies, and Chevron Nigeria.

The brands and organizations whose categories shape our research scope in Nigeria include these prominent players and many others across various sectors.

Why teams choose Global Vox Populi for Patient market research in Nigeria

Our Nigeria desk runs on senior researchers with 15+ years average tenure, bringing deep local healthcare sector understanding.

  1. We offer in-house translation and back-translation handled by native speakers of English, Yoruba, Hausa, and Igbo, delivering linguistic accuracy and cultural nuance.
  2. Clients benefit from a single project lead from kickoff through debrief, eliminating handoffs and maintaining consistent communication.
  3. Our ethical review processes for patient data are rigorous, providing confidence in compliance and respondent welfare.
  4. We also link to in-depth interviews in Nigeria for individual patient insights, and our broader qualitative research services in Nigeria deliver a holistic approach.

Frequently Asked Questions

Q: What kinds of clients commission patient market research in Nigeria?

A: We work with global pharmaceutical companies, medical device manufacturers, health technology firms, and healthcare providers. They seek to understand patient needs, treatment experiences, and perceptions of new therapies or services. We also work with NGOs and public health organizations focused on health outcomes.

Q: How do you deliver sample quality for Nigeria’s diverse patient population?

A: We employ precise screening criteria, often verifying diagnoses with medical records (with patient consent) and collaborating with healthcare facilities or patient advocacy groups. Our recruitment targets specific demographic and geographic quotas to reflect Nigeria’s diversity. Field teams are trained to engage sensitively and build trust with patients.

Q: Which languages do you cover in Nigeria for patient research?

A: We conduct patient market research in Nigeria in multiple languages to deliver broad reach and accurate understanding. Our capabilities include English, Yoruba, Hausa, Igbo, and Nigerian Pidgin. All moderators are native speakers and culturally attuned to the specific regional nuances.

Q: How do you reach hard-to-find patient audiences in Nigeria?

A: We use a multi-pronged approach for low-incidence patient groups. This includes using our network of specialist physicians, partnering with disease-specific patient associations, and conducting targeted intercepts at specialized clinics. For very specific conditions, we may employ snowball sampling under strict ethical oversight. We can also explore patient market research in Ghana for regional comparisons.

Q: What is your approach to data privacy compliance under Nigeria’s framework?

A: Our approach strictly adheres to the Nigeria Data Protection Act (NDPA) 2023. We secure explicit, informed consent for all patient data, making sure patients understand how their sensitive health information will be used and protected. Data is anonymized or pseudonymized where possible, and reliable security measures are in place throughout the research lifecycle.

Q: Can you combine patient market research with other methods?

A: Yes, we frequently integrate patient market research with other methodologies for richer insights. This might involve combining qualitative patient interviews with quantitative surveys among healthcare professionals (HCPs) or caregivers. We can also blend patient ethnography with digital diaries to capture real-world experiences. Tell us about your project challenges by clicking on our contact page.

Q: How do you manage cultural sensitivity in Nigeria’s patient research?

A: Cultural sensitivity is essential. Our local moderators are trained to understand and respect Nigeria’s diverse ethnic and religious contexts. Discussion guides are culturally adapted, and we avoid sensitive topics unless directly relevant to the research objective and handled with utmost care. We also consider local customs around health and illness.

Q: What deliverables do clients receive at the end of a patient market research project in Nigeria?

A: Clients receive comprehensive deliverables tailored to their needs. These typically include detailed qualitative reports with thematic analysis, patient journey maps, verbatim transcripts (translated and back-translated), and a debrief deck summarizing key findings and strategic implications. Raw data, anonymized where required, can also be provided.

Q: How do you handle quality assurance and back-checks for patient data?

A: Quality assurance involves several layers. We conduct audio checks of interviews, verify transcript accuracy against recordings, and perform back-translation for critical quotes. Our senior research team peer-reviews all analyses and reports. For quantitative elements, we implement logical checks and data cleaning protocols to deliver integrity.

Q: How do you select moderators or interviewers for patient research in Nigeria?

A: We select moderators and interviewers with relevant experience in healthcare or psychology, who are fluent in the local languages required. They undergo specific training in patient-centric interviewing techniques, ethical considerations for sensitive topics, and building rapport. Their cultural understanding of Nigeria is also a key selection criterion.

When your next research brief involves Nigeria, let’s talk through it. Request A Quote or View Case Studies from our work.

Request research

Let's begin

Ready to hear what your market actually thinks?

Tell us the decision you're trying to make. We'll come back with what we'd field — usually within four business hours.

Brief us on a study